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Gastrokine-1 (GKN1), a protein expressed in normal gastric tissue, but absent in gastric cancer tissues
and derived cell lines, has recently emerged as a potential biomarker for gastric cancer. To better
establish the molecular properties of GKN1, the first protocol for the production of mature human
GKN1 in the expression system of Pichia pastoris was settled. The recombinant protein showed anti-
proliferative properties specifically on gastric cancer cell lines thus indicating that it was properly folded.
Characterization of structural and biochemical properties of recombinant GKN1 was achieved by limited
proteolysis analysis, circular dichroism and fluorescence spectroscopy. The analysis of GKN1 primary
structure coupled to proteolytic experiments highlighted that GKN1 was essentially resistant to
proteolytic enzymes and showed the presence of at least a disulphide bond between Cys61 and one of
the other three Cys (Cys122, Cys145 and Cys159) of the molecule. The secondary structure analysis
revealed a prevailing b-structure. Spectroscopic and calorimetric investigations on GKN1 thermal
denaturation pointed out its high thermal stability and suggested a more complex than a two-state
unfolding process. The resulting protein was endowed with a globular structure characterized by
domains showing diﬀerent stabilities toward chemical and physical denaturants. These results are in
agreement with the prediction of GKN1 secondary structure and a three-dimensional structure model.
Our findings provide the basis for the development of new pharmaceutical compounds of potential use
for gastric cancer therapy.
Introduction
Gastric cancer (GC) is one of the most common solid tumors in
the world. High incidence rates are found in Japan, in some
regions of East Asia and in some Latin American countries,1,2
but the rates of mortality and incidence of the disease are very
high also in Europe. Despite advances in conventional thera-
pies, the survival rate of patients with GC up to 5 years is poor
(o30%), thus GC accounts for the fourth most commonly
diagnosed cancer and the second most common cause of
cancer-related death worldwide.3 The etiology of GC is multi-
factorial including environmental, genetic and infectious
factors.2,4–6 Multiple evidence demonstrated the important role
of Helicobacter pylori (H. pylori) infection in the development of
GC.6–8 Most of the H. pylori infected subjects develop acute
gastritis, which, if not properly treated, causes chronic disease,
and evolves into an ulcer or tumor.9 In two-thirds of patients in
Western countries, GC is diagnosed in an advanced stage, and
because this type of tumor is resistant to radiotherapy and
chemotherapy, surgery represents the only curative treatment,
although often it is only a temporary solution.10 Therefore,
there is an urgent need to clarify the molecular mechanisms
underlying the processes of transformation and neoplastic
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progression, to identify new prognostic parameters and to
develop more eﬀective therapies for GC.
Recently, the tissue-specific protein gastrokine-1 (GKN1) has
emerged as a possible biomarker for GC.11,12 This protein,
expressed in the human stomach of healthy individuals, is
absent in gastric adenocarcinoma tissues.13–15 Some evidence
suggests that GKN1 is involved in filling the lumen of the
surface layer of epithelial cells to maintain the integrity of the
mucosa and to regulate cell proliferation and diﬀerentia-
tion.12,13 As a result of the damage to the gastric mucosa, the
presence of GKN1 helps to restore the normal state of the
mucosa.16 In contrast, if the protein is not expressed, the repair
process is impaired. It has also been demonstrated that GKN1
expression induces apoptosis in GC cells, indicating the impor-
tance of GKN1 in inhibiting the development of GC.17 Indivi-
duals with a lower expression of the protein have an increased
risk of developing gastric diseases.18 The protein, in fact, is
downregulated in samples from H. pylori infected gastric
mucosa and is completely absent in GC.11,12,14,15 This protein,
previously known as 18 kDa antrum mucosal protein (AMP-18),
was subsequently called GKN1 by the ‘‘Human Gene Nomen-
clature Committee’’ for its tissue-specific expression and its
highly conserved presence in the gastric mucosa of many
mammalian species.12,13 The gene coding for GKN1 (CA11)
(accession number: BK0017373) is located on chromosome
2.19 Sequence analysis of the gene showed that the human
transcript contains two potential translation start sites (ATG).
The first start codon would generate a protein of 199 amino
acids whereas the second ATG, located 42 bp downstream,
would justify a protein of 185 amino acids. Among the two
starting sites, the second appears more possible since it
contains a Kozak sequence (GCAGCCAACATG).20 Comparison
of the translated amino acid sequence of human GKN1 with
that of other species showed homology only after the second
ATG, and its product is predicted to be of 18 kDa. In addition,
amino acid sequencing of native GKN1 from pig and N-terminal
Edman’s degradation of native human GKN1 confirmed that the
protein was made of 185 amino acids containing a 20 amino acid
extracellular signal peptide localized in the N-terminal region.13
The protein contains a conserved central structural BRICHOS
domain21 of about 100 amino acids containing two conservative
cysteine residues that are possibly involved in disulfide bridges.
The putative association of GKN1 with such a domain structure,
and with at least three diﬀerent possible functions, has been
proposed, but not conclusively demonstrated. In fact, the
BRICHOS domain has been found in proteins with a wide range
of functions and disease associations.22 These include the
transmembrane protein BRI2, which is related to familial British
and Danish dementia (FBD and FDD); chondromodulin-I
(ChM-I), related to chondrosarcoma; CA11, related to stomach
cancer; and surfactant protein C (SP-C), related to respiratory
distress syndrome (RDS).21
Although GKN1 seems to play an important role in gastric
mucosa and in the carcinogenic process, a full characterization
of its structure and biological activity is still lacking. The
purification of the protein from human tissues (normal human
antrum mucosa) is very diﬃcult due to the poor availability of
human specimens. In order to get more insight into the role of
GKN1 in gastric cancer, a recombinant production protocol
using the expression system of Pichia pastoris (P. pastoris) was
settled. The recombinant protein was biologically active in the
regulation of cellular viability. The physicochemical character-
ization of the purified recombinant GKN1 was achieved by
limited proteolysis, circular dichroism (CD), fluorescence
spectroscopy, and microcalorimetry. Bioinformatics tools were
used to predict a 3D model of the protein.
Experimental procedures
Microorganisms and culture media
P. pastoris GS115 strain was purchased from Invitrogen, and
used as a recombinant protein expression system. Culture
media for P. pastoris were prepared in Buﬀered Minimal
Glycerol (BMGY) consisting of 100 mM potassium phosphate,
pH 6.0, 1.34% yeast nitrogen base (YNB), 0.002% biotin, 1%
glycerol, or in Buﬀered Minimal Methanol (BMMY) consisting
of 100 mM potassium phosphate, pH 6.0, 1.34% YNB, 0.002%
biotin, 0.5% methanol. Ampicillin was purchased from Sigma,
and used at a concentration of 1 mg ml1.
Cloning and expression of GKN1 in P. pastoris
pCDNA3.1 containing the GKN1 cDNA (pCDNA3.1/GKN1)17 was
used to construct a pPIC9K expression vector for the production
of recombinant GKN1 in P. pastoris according to the procedure
reported in the ESI.†23 The protein concentration was deter-
mined according to the Lowry procedure.24
Cell culture
Human gastric adenocarcinoma (AGS), human embryonic
kidney (HEK293) and human lung epidermoid carcinoma
(H1355) cell lines were grown in DMEM-F12 (Dulbecco’s modi-
fied Eagle medium, Cambrex), DMEM and RPMI (Roswell Park
Memorial Institute), respectively, supplemented with 10% heat
inactivated fetal bovine serum (FBS), 1% penicillin/streptomycin
and 1% L-glutamine at 37 1C in a 5% CO2 atmosphere. The cells
were harvested by treatment with 0.25% trypsin containing
20 mM EDTA, washed with culture medium and re-suspended in
complete growth medium for studies of cell proliferation. The
cells were maintained in culture for no more than two weeks in
order to avoid the protracted passages in vitro that alter the
metastatic phenotype.
Cell viability assay
Cell proliferation was assessed using a MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay
(Sigma). Re-suspended cells (about 5000 cells per well) were
plated in 96-well plates and starved overnight. Cells were then
treated with diﬀerent concentrations of recombinant GKN1
(0.5, 3.0, 5.5, 11.0 and 18.0 mM) for diﬀerent time intervals
(0, 12, 24 and 48 hours or 0, 24, 48 and 120 hours). Subsequently,
the MTT solution was added to the wells (0.5 mg ml1 final
concentration), and the plates were incubated for additional
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4 hours at 37 1C. The reaction was stopped by removing the
supernatant followed by the dissolution of the formazan
product by the addition of 100 ml of isopropanol. The absorbance
at 570 nm was determined using a Bio-Rad ELISA reader. Cell
proliferation was expressed as the percentage of formazan
formation in the treated samples, compared to the negative
control treated only with solvent.
Limited proteolysis
Samples of purified GKN1 (80 mg) were incubated in 20 mM
Tris–HCl, pH 7.8, 1 mM MgCl2, 50 mM KCl, 1 mM b-mercapto-
ethanol with 0.8 mg of trypsin, chymotrypsin or thermolysin at
37 1C in a final volume of 80 ml. At selected times, 20 ml aliquots
were withdrawn from the reaction mixture and analysed by
SDS-PAGE.25 The N-terminal amino acid sequence of the
products was determined after their transfer on a membrane
for microsequencing (Problot) in CAPS using an automatic
sequencer (Mod 473 A, Applied Biosystem) connected online
to a HPLC apparatus for PTH-amino acid identification.25
Western blotting
Proteins were separated by SDS-PAGE, electro-transferred to a
PVDF membrane, and incubated for 1 h at room temperature
with GKN1 monoclonal antibody, clone 2E5 (Abnova), at 1 : 500
dilution. Anti-mouse secondary antibody conjugated with
horseradish peroxidase (HRP) (Santa Crutz, DBA) was used at
1 : 20 000 dilution. The immunoreacted protein bands were
visualized using an enhanced chemiluminescence detection
reagent (SuperSignal West Pico), exposed to X-ray film, scanned
at 1200 dpi resolution and bands were quantified by using
Image J software.26
Circular dichroism and fluorescence spectroscopy
Sample solutions for spectroscopic measurements were pre-
pared in a 20 mM sodium phosphate buﬀer at pH 8.5, and the
protein concentration was determined by UV absorption read-
ing using a theoretical, sequence-based extinction coeﬃcient of
30 680 M1 cm1 at 280 nm.27 CD spectra were recorded using a
Jasco J-715 spectropolarimeter equipped with a Peltier type
temperature control system (Model PTC-348WI). Molar ellipti-
city per mean residue, [y] in deg cm2 dmol1, was calculated
from the equation [y] = [y]obs mrw/10 lC, where [y]obs is the
ellipticity measured in degrees, mrw is the mean residue
molecular weight of GKN1 (111.3 Da), C is the protein concen-
tration in g ml1 and l is the optical path length of the cell in
cm. Molar ellipticity in the near-UV region was calculated per
protein molar concentration (m) by using the equation [y] =
[y]obs100/ml. CD spectra were recorded by using 0.1 and 0.5 cm
path length cells in the far-UV and near-UV region, respectively.
For thermal stability studies, spectra were recorded at diﬀerent
temperatures; for denaturant stability investigations, spectra
were recorded at 25 1C (constant time 4 s, bandwidth 2 nm,
scan rate 20 nm min1) by varying the GdnHCl or urea
concentration. Spectra were signal-averaged over three scans
and the baseline was corrected by subtracting the buﬀer
spectrum. Far-UV CD spectra were analyzed for secondary
structure estimation by means of the CDSSTR method28 as
implemented in Dichroweb.29,30
Thermal unfolding curves were recorded in the far-UV
region at 216 nm and 222 nm, and in the near-UV region at
270 nm and 290 nm, from 0 1C to 85 1C, every 0.5 1C with a scan
rate of 1 1C min1 at a protein concentration of 0.15 or
1.0 mg ml1 in 0.1 or 0.5 cm cells, respectively. They were
analyzed assuming a two-state N# D unfolding mechanism in
order to calculate the denaturation temperature and enthalpy,
as previously described.31 The denaturant-induced unfolding
was monitored by following changes in the CD signal at 222 nm
of solutions containing an identical concentration of GKN1 in
20 mM sodium phosphate buﬀer at pH 8.5, which was pre-
viously incubated overnight at 25 1C with increasing concen-
tration of GdnHCl or urea. The concentrations of denaturant
stock solutions were derived from refractive index measure-
ments.32 Data were collected using a 0.1 cm path length cell,
and ellipticity was averaged over 8 seconds. To estimate the
reversibility, the spectra of the unfolded samples of GKN1,
upon suitable dilution of denaturant, were recorded at 25 1C.
Data were then analyzed in the assumption of a two-state N#
D transition, by means of a linear extrapolation model (LEM).32
It is assumed that the standard denaturation Gibbs energy
change is a linear function of the denaturant concentration
[den] according to the equation:
DdG ¼ DdGH2O  ðm  ½denÞ (1)
where DdGH2O is the value of DdG in the absence of denaturant
and m is a measure of the dependence of DdG on denaturant
concentration. Furthermore, DdGH2O ¼ m  ½den1=2, where
[den]1/2 is the midpoint of the denaturation process. Denatura-
tion curves were analyzed as already described.33 Least squares
fitting of the data was performed using the software package
Origin7.5.
Fluorescence spectra were recorded at 25 1C on a computer
assisted Cary Eclipse spectrofluorometer (Varian) at a scan rate
of 60 nm min1 using an excitation wavelength of 280 nm;
excitation and emission slits were set to 10 nm. The fluore-
scence spectrum was measured in the range 300–450 nm on
samples treated in the absence or in the presence of diﬀerent
denaturant concentrations as reported above.
Diﬀerential scanning calorimetry
DSC measurements were performed on a nano-DSC (TA Instru-
ments). The excess molar heat capacity function, hDCPi, was
obtained after a baseline subtraction, assuming that the base-
line is given by the linear temperature dependence of the
native-state heat capacity. A buﬀer–buﬀer scan was subtracted
from the sample scan. The two-state model based van’t Hoﬀ
enthalpy was calculated by the formula:34
DdH(Td)
vH = 4RTd
2 hDCp(Td)i/DdH(Td) (2)
where Td is the denaturation temperature corresponding to the
maximum of the DSC peak, hDCp(Td)i is the height of the excess
heat capacity at Td, DdH
cal is the total denaturation enthalpy
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change calculated by direct integration of the area of the DSC
peak and R is the gas constant. A scan rate of 1 1C min and a
protein concentration of about 0.4 mg ml1 in 20 mM sodium
phosphate buﬀer, pH 8.5, were chosen for the experiments.
Bioinformatic analysis
Protein secondary structure prediction was done using
PSIPRED (Protein Structure Prediction Server, UCL Department
of Computer Science, USA). Protein sequences and alignment
were obtained from UniProtr 2002–2012 (Universal Protein
Resource Consortium, Cambridge, United Kingdom; Geneva,
Switzerland; Washington, United States of America). GKN1 3D
structural models were computed using I-Tasser Server (Center
for Computational Medicine and Bioinformatics, University of
Michigan, USA)35,36 and Swiss Model.37 Quality assessment of
the obtained 3D model was performed using Molprobity server
(3D Macromolecular Analysis & Kinemage home page, at the
Richardson Laboratory, Department of Biochemistry, Duke
University, USA).38,39 All pdb structures were analyzed and
visualized by using the PyMol Molecular Graphics System,
Version 1.2r3pre, Schro¨dinger, LLC.
Results
Expression and purification of recombinant GKN1
The cDNA encoding mature GKN1 (lacking the 20 aa hydro-
phobic N-terminal region) was cloned into the methanol inducible
expression vector pPIC9K, and expressed in P. pastoris
according to the procedure reported in the ESI† (Fig. S1–S3).
The total amount of GKN1 purified from 1 liter of culture
medium was around 40 mg.
Biological activity of recombinant GKN1
GKN1 has been reported to aﬀect cell viability,13 therefore, the
ability of the recombinant protein to aﬀect cell proliferation
in vitro using diﬀerent cell cultures was evaluated. The results
(Fig. 1) showed that GKN1 was endowed with an anti-
proliferative eﬀect at a concentration of 0.5 mM after 24 h of
treatment of the AGS cell line (Fig. 1A and B). The eﬀect of the
protein was dose dependent since the inhibition of cell growth
was higher at higher GKN1 concentration. A less marked eﬀect
was instead observed using as controls a nongastric cancer cell
line (H1355) (Fig. 1C) or a normal cell line (HEK 293) although
for the latter higher concentrations of GKN1 were required
(Fig. 1D). These results indicated that the recombinant GKN1
was able to exert its function specifically in gastric cancer cells
and therefore was appropriate for studying the molecular
properties in detail.
Exposed proteolytic sites of recombinant GKN1
The first approach to get an insight into the molecular properties
of GKN1 was suggested by the finding that this protein exerted
its action in the antrum of the stomach where an extreme
environment, characterised by a low pH and the presence of
proteases, is found. To this aim, the purified protein was
analyzed by limited proteolysis using trypsin, chymotrypsin
and thermolysin. From the SDS-PAGE profile of time-dependent
enzymatic digestion, only a few GKN1 fragments were generated
(Fig. S4, ESI†), thus indicating that the protein was endowed with
an intrinsic compactness, in which proteolytic sites were buried
in the solvent. A schematic representation of the proteolytic sites
in GKN1 is reported in Fig. 2. In particular, as numbered in
mature GKN1, trypsin was able to cleave the protein at the level
of Lys89 which was located between Cys61 and the other three
cysteines (Cys122, Cys145 and Cys159) whereas chymotrypsin
and thermolysin were able to cleave GKN1 mainly at residues
located in a region close to the main tryptic site (His64, Tyr101,
Phe139 and Lys85 and Phe139, respectively). To test whether the
cysteines were involved in a disulfide bond, a trypsin digestion of
GKN1 under both reducing and non-reducing conditions was
performed. The results obtained (Fig. S5, ESI†) suggested that
Fig. 1 Eﬀect of GKN1 on cell growth. The eﬀect of GKN1 on cell growth was
performed using the MTT procedure after incubation of the cells with GKN1 at
diﬀerent times and concentrations. (A and B) AGS cell growth in the absence (K)
or in the presence of 0.5 mM (J) or 3 mM (n) GKN1. (C) H1355 cell growth in the
absence (K) or in the presence of 0.5 mM (J) or 3 mM (n) GKN1. (D) HEK 293 cell
growth in the absence (K) or in the presence of 5.5 mM (J), 11 mM (n) and
18 mM (&) GKN1, respectively.
Fig. 2 Schematic representation of GKN1 proteolytic sites. (A) Structural
organization and amino acid sequence of recombinant His-tagged GKN1 showing
in red the amino acids involved in the proteolytic cleavage. (B) Schematic
representation of the proteolytic site position. Chymotrypsin (chm), thermolysin
(trm), trypsin (trp).
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under non-reducing conditions a disulfide bond between Cys61
and one of the other three cysteines of GKN1 was present.
GKN1 thermal stability
Thermal stability of GKN1 was investigated by both spectro-
scopic and calorimetric measurements. Fig. 3A shows the
far-UV CD spectra of GKN1 in 20 mM phosphate buﬀer,
pH 8.5 recorded at 5 1C (solid line) and 85 1C (dashed line)
and at 5 1C after cooling (dotted line). The estimation of the
secondary structure content was performed on the spectrum
recorded at 5 1C (solid line) by means of the CDSSTR method28
as implemented in Dichroweb.29,30 The results indicated that
GKN1 possesses a prevailing b-structure in fact, using reference
database SP17540 the calculated secondary structure fractions,
with a NRMSD value of 0.021, were: 16% a-helix, 32% b-strands,
12% turns and 40% unordered content. The CD spectrum
recorded at 85 1C (dashed line) suggested that the thermal
unfolded protein still retained some amount of secondary
structure. The far-UV CD spectra of GKN1 recorded from 5 1C
to 85 1C, reported in Fig. S6 (ESI†), indicated that small but
highly cooperative changes of GKN1 secondary structure
occurred at increasing temperature. These changes were very
small at 222 nm and more pronounced at 216 nm. Since the CD
signals at 222 nm and at 216 nm are characteristic for protein
containing a-helix and b-sheet conformation, respectively, to
better detect the temperature-induced changes,41 we recorded
thermal denaturation curves at both these wavelengths. The
results obtained (Fig. 3B and C) showed a single cooperative
inflection point in both cases. The van’t Hoﬀ analysis of these
thermal unfolding curves yielded a midpoint (Td) of 81 1 1C
and the unfolding enthalpy of DHvH of 450  27 kJ mol1.
Furthermore, if the heating temperature did not exceed 85 1C,
GKN1 thermal denaturation showed to be reversible as revealed
by the return of the complete spectrum upon thermal unfolding
followed by subsequent cooling to 5 1C (Fig. 3A, dotted line).
Fig. 4A reports the CD spectra of GKN1 in the near-UV region
recorded from 5 1C to 85 1C. The spectrum at 5 1C showed a
positive band at around 290 nm characteristic of tryptophan
residues with a fine structure, and a more intense negative
band at around 270 nm characteristic of tyrosine residues with
a fine structure. The presence of bands in this spectral region
was indicative of a defined tertiary structure of the recombinant
Fig. 3 Far-UV CD spectra of GKN1. (A) Far-UV CD spectra of GKN1 in 20 mM
phosphate buﬀer at pH 8.5, recorded at 5 1C (solid line) or at 85 1C (dashed line);
the dotted line represents the spectrum of the latter after cooling at 5 1C. (B and C)
Thermal denaturation curve of GKN1 in 20 mM buﬀer at pH 8.5, recorded by
following changes in the CD signal (’) at 216 nm and 222 nm (’), respectively.
Fig. 4 Near-UV CD spectra of GKN1. (A) Near-UV CD recorded in the temperature
interval 5 1C–85 1C. (B and C) Thermal denaturation curves of GKN1 in 20 mM
phosphate buﬀer at pH 8.5, recorded by following changes in the CD signal at
290 nm (’) and 270 nm (’), respectively.
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GKN1. This fine structure disappeared when the spectrum was
recorded at 85 1C. This behaviour clearly indicated that thermal
denaturation of GKN1 provoked the complete loss of its tertiary
structure. A closer inspection of the denaturation process was
carried out by monitoring changes in the CD signal both at
270 nm and at 290 nm as a function of temperature. Both the
denaturation curves, reported in Fig. 4B and C, respectively,
had a sigmoidal shape with an inflection point at 75 1C,
although they clearly showed a diﬀerent slope especially
in the pre-denaturation region. In particular, the change in
the CD signal at 270 nm showed a higher slope at increasing
temperature, suggesting that, on average, the tyrosine structural
proximities are most aﬀected by temperature.
A DSC curve of GKN1, recorded in a 20 mM sodium
phosphate buﬀer at pH 8.5, is reported in Fig. 5. A comparable
curve was obtained in a second heating of a sample previously
heated up to 80 1C (data not shown). Thus, according to the
reheating criterion, the thermal unfolding of GKN1 can be
considered as a reversible process. Values of denaturation
temperature (Td) and calorimetric enthalpy change (DdH) were
81.2  0.2 1C and 320  17 kJ mol1, respectively. The van’t
Hoﬀ enthalpy change based on a two-state model denaturation
process was 450  40 kJ mol1, in very close agreement with CD
results.
GKN1 denaturant-induced unfolding
Denaturant-induced unfolding of GKN1 was investigated by
means of CD and fluorescence measurements. Fig. 6A reports
the changes in GKN1 molar ellipticity at 222 nm as a function
of GdnHCl or urea concentration. The denaturation curves
indicated that: (a) GKN1 has a very diﬀerent resistance towards
the denaturing action of GdnHCl and urea; in fact the
midpoints corresponding to the denaturant concentration at
half-completion of the transition were 1.9 M for GdnHCl and
7.8 M for urea; and (b) a significant content of protein secondary
structure was still present in the urea-induced denaturation as
indicated by the negative value of the CD signal at 222 nm even
at high concentrations of urea. As the denaturant-induced
unfolding of GKN1 proved to be a reversible process, a thermo-
dynamic analysis was performed assuming a two state, N# D
model for the unfolding process. The extrapolation to zero
denaturant concentration resulted in a Gibbs energy diﬀerence
(DGH2O) of 26.8 2.5 kJmol1 for GdnHCl and 29.8 3.7 kJmol1
for urea unfolding, respectively. The corresponding denatura-
tion m values were 14.1  1.3 and 3.7  0.5 kJ mol1 M1 for
GdnHCl and urea, respectively.
The fluorescence emission spectrum of GKN1 showed a
maximum at 344 nm, upon excitation at 280 nm, that was
indicative of a protein with a globular structure42 in which
aromatic residues were rather exposed to the solvent. Even in
this case, the spectra recorded upon GdnHCl or urea denatura-
tion denoted a diﬀerent behaviour between the two denatur-
ants. In particular, at increasing concentration of GdnHCl
(Fig. 6B), a significative fluorescence quenching, accompanied
by a red shift of wavelength of the maximum, was observed;
conversely, at increasing concentration of urea (Fig. 6C), only a
small increase in the fluorescence intensity was found. In the
case of GdnHCl, the concentration of denaturant for half
denaturation derived from either the red-shift in the maximum
or the intensity quenching (not shown) was very similar to that
Fig. 5 DSC profile of GKN1 recorded at pH 8.5 in 20 mM phosphate buﬀer.
Fig. 6 Urea- and GdnHCl-induced unfolding of GKN1. (A) Change in the CD
signal at 222 nm in 20 mM phosphate buﬀer pH 8.5 and 20 1C at increasing
concentration of denaturant. Fluorescence emission spectra of native GKN1 in
the absence (dashed line) or in the presence of increasing amounts of GdnHCl
(B) and urea (C), respectively.
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measured in the denaturant-induced unfolding of GKN1
followed by CD. Regarding the eﬀect of urea of the fluorescence
spectrum of GKN1, the modest quantum yield increase
although did not allow this kind of calculation, still indicated
an exceptional resistance of GKN1 to this hydrogen-bond
destroyer denaturant.
GKN1 structure prediction
GKN1 homologous sequences including proSPC were selected
and aligned using Uniprot server (Fig. S7, ESI†). For each
sequence the content of secondary structural elements (H, helix;
E, extended; C, coil) was evaluated using PSIPRED server and the
predicted structures were compared considering the sequence
alignment (Fig. S8, ESI†).
I-Tasser server predicted for recombinant GKN1 five top
models on the basis of top ten templates (Table S1 and
Fig. S9, ESI†). Swiss Model instead generated a GKN1 3D model
using the BRICHOS domain of proSP-C (pdb 2yadA) as a
template.43 The quality of the predicted GKN1 structures was
checked using Molprobity server (model 1-3FH and model 1FH,
respectively). Comparison of structural parameters of both
models (Table S2 and Fig. S10, ESI†) suggested that model
1FH appeared to be more reliable.
Discussion
In this study, the structural and biochemical properties of
recombinant human GKN1 lacking the hydrophobic N-terminal
peptide, heterologously expressed in the yeast P. pastoris, were
investigated. The use of this protein expression system was
suggested by the fact that the heterologous expression of GKN1
in E. coli always gave a product that accumulated into inclusion
bodies, even when the expression was carried out at 15 1C (data
not shown), and attempts to refold the protein from inclusion
bodies were unsuccessful. In contrast, the expression of GKN1
in yeast allowed the production of a soluble form of GKN1 that
was purified at high yield. In addition, the capability of recom-
binant GKN1 to be soluble at relatively high concentration
(E6 mg ml1) suggested that the protein was correctly folded.44
This finding was also confirmed by the ability of recombinant
GKN1 to exert a higher antiproliferative eﬀect on AGS with
respect to H1355 and HEK293 human derived cell lines. The
higher sensitivity of AGS cells to GKN1 exposure was likely
linked to the role played by GKN1 in maintaining gastric
mucosal integrity and to its function as a gastric tumor
suppressor. In fact, inactivation of GKN1 gene in normal gastric
cells could play an important role in the development and/or
progression of gastric cancer.45 The data obtained were also in
agreement with our previous finding indicating that AGS cells
overexpressing GKN1, compared to H1355 cells, showed higher
expression of Fas receptor and sensitivity to Fas-ligand induced
apoptosis.17 Therefore, to investigate on the structural features
of GKN1, biochemical and spectroscopic properties of the
expressed protein were analyzed. To identify exposed regions
of GKN1, limited proteolysis experiments were performed
showing that the protein was moderately resistant to proteases.
Time-course reactions with trypsin, chymotrypsin and thermo-
lysin showed only a partial degradation of the protein with
proteolytic cleavages located within the specific region of the
protein. Protease resistance was also reported for GKN1
purified from chicken gizzard smooth muscle.46 However, in
the latter case, the protein was cleaved by trypsin only at its
N-terminal giving rise to a 18 kDa resistant core protein, in
agreement with the evidence that some proteins containing the
BRICHOS domain are similarly cleaved.21 Because GKN1 is
highly expressed in human normal stomach mucosal antrum
and thus exposed to an harsh environment, its stability against
degradation is highly required. Moreover, GKN1 appeared to
be further stabilized by the presence of a disulfide bridge
occurring between Cys61 and one of the other three cysteine
residues (Cys122, Cys145 or Cys159) present in the molecule.
However, multiple alignment of several GKN1 homologous
proteins (Fig. S7, ESI†), including BRICHOS domain containing
proteins such as pulmonary surfactant protein C (PSPC),
showed that among all conserved cysteines, only the first two
are present in all sequences. In addition, despite the low
sequence identities, the prediction of secondary structure of
these sequences highlighted from their comparison that the
secondary structural elements showed a similar organization
(Fig. S8, ESI†). Because in the 3D structure of human proSP-C43
the first two common cysteines (Cys121 and Cys189) form a
disulfide bridge, it is likely that also in GKN1 the corresponding
Cys61 and Cys122 might form a bridge. No finding is reported
up to now concerning the involvement of GKN1 cysteines in the
interaction with other partner proteins, as instead it occurs
between the homologous human GKN2 and trefoil factor 1
(TFF1) which were bound through a disulfide bridge.47,48
However, compared to GKN1, GKN2 contains an additional
cysteine residue that could be involved in this interaction.48
CD spectroscopy experiments highlighted that GKN1
showed a content of b-structures higher than a-helix. In
particular, the far-UV CD spectrum was quite similar to that
of b1-proteins showing a positive band at around 190 nm with a
negative shoulder at around 220 nm.49 A prediction of the
secondary structure of recombinant GKN1 (33.3% b-sheet and
14.5% a-helix) was consistent with that determined on the basis
of CD spectroscopy.
Regarding the thermal stability, our data suggested that the
protein was endowed with a considerable high stability for a
mesophilic protein, in fact the main cooperative denaturation
event occurred above 80 1C as highlighted by calorimetric and
far-UV CD thermal denaturation curves. However, the results of
near-UV CD thermal denaturation indicated that the protein
tertiary structure appeared to be impaired already at 75 1C, thus
suggesting that the protein was characterized by the presence
of at least two diﬀerent temperature sensing regions. In fact,
the diﬀerent calorimetric and van’t Hoﬀ enthalpy values
confirmed that the two-state model did not adequately
described the GKN1 thermal denaturation process. Furthermore,
the CDmelting profiles in the far and near UV suggested that the
denaturation process of the protein was more complex than a
simple two-state mechanism which leads to a compact
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denatured state. The loss of the sharp peaks in the near-UV CD
coupled to a much smaller changes in the far-UV CD have been
used as a signature to characterize a molten globule state.50,51
The GKN1 conformational stability was studied by means of
denaturant-induced unfolding measurements. These results
indicated that although both urea and GdnHCl aﬀected the
GKN1 conformational stability, the latter was four-fold more
eﬀective than the urea which likely give rise to a much more
compact unfolding state. Urea and GdnHCl have very similar
chemical structures and the main diﬀerence resides on the fact
that the latter is a charged species at neutral pH52 however,
their denaturing eﬀect is diﬀerent and in particular, GdnHCl
mainly aﬀected ion pairs, whereas urea is considered an
hydrogen-bonding destroyer.52 Therefore, the analysis of the
concentration of the two denaturants to get an eﬀect indicates
that, at least under our experimental conditions, electrostatic
interactions play a less important role in the stability of the
protein compared to that exerted by hydrogen bonding in GKN1
stabilisation. These results suggest that the high resistance of
GKN1 against the denaturing action of urea is possibly due to
the role played by hydrogen-forming residues in protein stability.
This hypothesis can be supported by the high content of Asn
residues (about 13%) present in the protein. In addition, the
fluorescence emission spectrum of GKN1 was also in agreement
with the predicted GKN1 3D structure in which most of the
aromatic residues are rather exposed to the surface.
The structural features determined by CD and fluorescence
analyses are in agreement with predictions of secondary
structure made for proteins containing the BRICHOS domain.53
Generally, BRICHOS proteins have four regions: hydrophobic,
linker, BRICHOS and C-terminal domains.22 Residue conserva-
tion diﬀers considerably among these regions, however, the
BRICHOS region of all components of the protein family
showed the highest sequence identity only for two cysteines
and one aspartate strictly conserved (D45 in GKN1) thus
indicating that this domain should exert a similar function in
all the proteins of the family.22 For instance, the corresponding
cysteines in the proSP-C superfamily form an internal
disulphide bridge and their strict conservation in the BRICHOS
family suggests that the disulphide bridge is also present in all
BRICHOS domain members.54 These findings indicated that
these proteins might have well defined tertiary structures.43
Therefore, 3D GKN1 models were computed using bioin-
formatic servers and tested for their quality. A plausible model
(model 1FH) showed that Cys61 was closer to Cys122 and that
the Lys89 was positioned in an almost exposed region in
agreement with the proteolytic results. Moreover, the 3D model
of GKN1 could be in agreement with the spectroscopic data and
suggests the presence in the protein of two distinct domains.
The ongoing determination of GKN1 crystallographic structure
will clarify these hypotheses.
Conclusions
The data reported on the molecular and functional properties
of human GKN1 seem to indicate a more significant propensity
for b-sheet structures and this result was coherent with those
predicted for the protein families containing the BRICHOS
domain. The protein appears to be endowed with an external
flexible region susceptible to the action of an ionic chemical
denaturant and with a thermal resistant compact region most
likely stabilized by strong hydrogen bond. The analysis of the
3D model of the protein suggested that the b-sheet side chains
are conserved within BRICHOS domains not only because they
are strictly required for formation of the hydrophobic core, but
also because they are probably involved in some other
functions, such as the possibility of peptide binding as reported
for the surfactant protein C.Moreover, the finding that recombinant
human gastrokine 1 showed antitumoral properties provides
the basis for the development of new pharmaceutical
compounds of potential use for gastric cancer therapy.
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AMP-18 18 kDa antrum mucosal protein
BMGY buﬀered minimal glycerol
BMMY buﬀered minimal methanol
CD circular dichroism
DSC diﬀerential scanning calorimetry
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Dulbecco’s modified Eagle medium
DTT dithiothreitol
GC gastric cancer
FBS fetal bovine serum
GKN1 gastrokine-1
GdnHCl guanidinium hydrochloride
HPLC high performance liquid chromatography
HRP horseradish peroxidase
MEM minimum Eagle’s Medium
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide
NRMSD normalized root mean square deviation
PTH phenylthiohydantoin
PVDF polyvinylidene fluoride
YNB yeast nitrogen base
YPD yeast peptone dextrose medium
TFA trifluoroacetic acid
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